CL
IRWD icon

CSS LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

CSS LLC’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20,000
Closed -$266K – 696
2019
Q4 		$266K Buy
+20,000
New +$221K 0.01% 457
2017
Q3 		– Sell
-27,343
Closed -$433K – 644
2017
Q2 		$433K Buy
+27,343
New +$397K 0.02% 374

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CSS LLC's IRWD Position: Q3 2020 in Review

CSS LLC sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 24,702 shares — an estimated $255K sold.

CSS LLC first reported a position in IRWD in Q2 2020 and held it in 1 quarter. The position peaked at $255K in Q2 2020. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

  • CSS LLC reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • CSS LLC sold 24,702 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $255K.
  • CSS LLC first reported a position in Ironwood Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • CSS LLC's Ironwood Pharmaceuticals position peaked at $255K in Q2 2020.
  • 190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on CSS LLC's 13F filing for Q3 2020, filed 16 Nov 2020.